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The stromal scaffold of the lymph node (LN) paracor-
tex is built by fibroblastic reticular cells (FRCs). Con-
ditional ablation of lymphotoxin-b receptor (LTbR)
expression in LN FRCs and their mesenchymal pro-
genitors in developing LNs revealed that LTbR-
signaling in these cells was not essential for the for-
mation of LNs. Although T cell zone reticular cells
had lost podoplanin expression, they still formed a
functional conduit system and showed enhanced
expression of myofibroblastic markers. However,
essential immune functions of FRCs, including ho-
meostatic chemokine and interleukin-7 expression,
were impaired. These changes in T cell zone reticular
cell function were associated with increased suscep-
tibility to viral infection. Thus, myofibroblasic FRC
precursors are able to generate the basic T cell
zone infrastructure, whereas LTbR-dependent matu-
ration of FRCs guarantees full immunocompetence
and hence optimal LN function during infection.
INTRODUCTION
Lymph nodes (LNs) and other secondary lymphoid organs
(SLOs) provide particular microenvironments for optimal induc-
tion and control of immune responses (Junt et al., 2008; Mueller
andGermain, 2009). These specialized niches are generated and
maintained by different sets of vascular and mesenchymal stro-
mal cells (Randall et al., 2008; Turley et al., 2010). The mesen-
chymal stromal cell network of the LN T cell zone is formed by
fibroblastic reticular cells (FRCs) which are characterized by
the expression of podoplanin (PDPN), and extracellular matrix
proteins such as ERTR-7 and collagen-I (Malhotra et al., 2012).
Furthermore, FRCs regulate immune homeostasis and reactivitythrough the production of homeostatic chemokines, the im-
mune-regulatory cytokine interleukin-7 (IL-7) (Link et al., 2007),
and small molecules such as nitric oxide (Lukacs-Kornek et al.,
2011; Siegert et al., 2011). However, although LN FRCs are
phenotypically well-characterized (Katakai et al., 2004; Malhotra
et al., 2012), their development from mesenchymal precursors
has remained elusive.
The differentiation of FRCs from their progenitor(s) is thought
to be closely linked to lymphoid organogenesis. The early steps
of both LN and Peyer’s patch (PP) organogenesis involve the
appearance of hematopoietic lymphoid tissue inducer (LTi) cells
in the respective anlagen (Mebius et al., 1997; Yoshida et al.,
1999). Lymphotoxin-b receptor (LTbR) and receptor activator
of NF-kB ligand (RANKL)-mediated interaction of LTi cells with
mesenchymal stromal cells in the LN or PP anlage is thought
to be critical for their further development (van de Pavert and
Mebius, 2010; Randall et al., 2008). Indeed,mice lacking LTi cells
fail to generate both LNs and PPs (Eberl et al., 2004; Boos et al.,
2007) andmolecules of the tumor necrosis factor (TNF) family ex-
pressed by LTi cells provide essential signals for the developing
SLOs (De Togni et al., 1994; Koni et al., 1997; Kong et al., 1999).
LTbR engagement on stromal cells appears to be particularly
important because the expression of IL-7, C-C motif chemokine
19 (CCL19), and CCL21 generates a positive feedback loop that
attracts and activates further LTi cells (Honda et al., 2001; Ohl
et al., 2003). Mesenchymal stromal cells interacting with LTi cells
during prenatal stages of SLO development are commonly
referred to as lymphoid tissue organizer (LTo) cells and have
been described as intercellular adhesion molecule 1 (ICAM-1)-
and vascular cell adhesion molecule 1 (VCAM-1)-expressing
cells that appear around embryonic day (E) 16 in the murine LN
anlage (Cupedo et al., 2004c; White et al., 2007). Gene-expres-
sion analysis revealed that these cells provide molecules
involved in LN organogenesis including LTbR, RANKL, CCL19,
CCL21, CXCL13, and IL-7 (Cupedo et al., 2004c; Be´ne´zech
et al., 2010). However, neither global gene ablation of LTbR-
ligands (De Togni et al., 1994; Koni et al., 1997) or the LTbR itself
(Fu¨tterer et al., 1998), nor LTbR expression on mesenchymalImmunity 38, 1013–1024, May 23, 2013 ª2013 Elsevier Inc. 1013
Figure 1. Ccl19-cre Transgene Expression in LN Stromal Cells
(A) LN cell suspensions from 6-week-old Ccl19-cre 3 R26-eyfp mice were
depleted of CD45+ cells, and EYFP expression was determined by flow cy-
tometry.
(B) Representative dot plot analysis with quadstat values of CD31 and PDPN
expression in CD45 inguinal LN stromal cells.
(C) Dot plot analysis including quadstat values of CD31 and PDPN expression
in CD45EYFP+ LN stromal cells.
(D) EYFP expression in CD45 LN stromal cell populations (PDPN+CD31
fibroblastic reticular cells [FRC]; PDPNCD31 double-negative [DN] cells;
PDPN+CD31+ lymphatic endothelial cells [LECs]; PDPNCD31+ blood endo-
thelial cells [BEC]). Inguinal LNs from individual mice were pooled, mean
values ± SEM from 15 mice analyzed in three independent experiments.
(E) Confocal microscopic analysis of an Ccl19-cre 3 R26-eyfp inguinal LN
section by using antibodies against the indicatedmarkers, merged channels in
left panel; scale bar represents 200 mm.
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1014 Immunity 38, 1013–1024, May 23, 2013 ª2013 Elsevier Inc.stromal cells of the LN anlage (Cupedo et al., 2004c; White et al.,
2007; Be´ne´zech et al., 2010) has allowed for the determination of
the developmental window of LTbR-dependent mesenchymal
LTo cell stimulation that is critical for LN or PP development.
Deletion of genes in a cell-specific and spatiotemporally
controlled manner can be achieved by utilizing the Cre-loxP
system. Here, we report the generation of a bacterial artificial
chromosome (BAC)-transgenic mouse model that utilizes the
Ccl19 promoter to target the Cre recombinase specifically to
mesenchymal stromal cells of the developing LN and to FRCs
and FRC-like cells in adult LNs and PPs, respectively. Surpris-
ingly, ablation of the LTbR on Ccl19-cre+ mesenchymal stromal
cells did not abrogate LN development. Moreover, although the
maturation of LN FRCs from myofibroblastic precursors was
blocked in Ccl19-cre 3 Ltbrfl/fl mice, the basic infrastructure of
the adult LN with T and B cell zone segregation and a functional
conduit system was established. However, Ccl19-cre 3 Ltbrfl/fl
mice were immunodeficient because myofibroblastic FRC
precursors were devoid of essential immune-stimulatory proper-
ties such as production of homeostatic chemokines and IL-7.
Moreover, conditionally FRC-deficient animals showed an
impaired resistance to viral infection, indicating that LTbR-
mediated FRC maturation is critical for the maintenance of
immunocompentence.
RESULTS
Genetic Targeting of LN FRCs
Currently, LN FRCs are defined as PDPN+CD31 stromal cells in
the T cell zone and interfollicular regions expressing smooth
muscle actin (SMA) and the extracellular matrix protein ERTR7
(Link et al., 2007; Malhotra et al., 2012). However, neither of
these markers is truly FRC-specific. For example, PDPN is ex-
pressed on different stromal cell populations (Malhotra et al.,
2012) and hencePdpn-cre transgenes target both PDPN+CD31
FRCs and PDPN+CD31+ lymphatic endothelial cells (LECs)
(Onder et al., 2011). Here, we utilized the Ccl19 promoter to
direct Cre recombinase expression to LN FRCs. To silence the
Ccl21 gene, which is in close proximity to the Ccl19 locus, the
murine Ccl21 gene was replaced by the human CD8 gene in
the BAC construct. Crossing of transgenic lines with R26-eyfp
reporter mice (Srinivas et al., 2001) facilitated screening for foun-
ders with exclusive transgene expression in nonhematopoietic
cells (Figure 1A; see also Figures S1A and S1B available online).
Because two out of seven founder lines showed identical stromal
cell-specific transgene expression, all further analyses were
performed with founder line 1 designated as Ccl19-cre. Staining
of CD45 LN cells with antibodies against PDPN and CD31
revealed a normal LN stromal cell composition in Ccl19-cre 3
R26-eyfp mice (Figure 1B). Importantly, FRC specificity was
high with 80%–90% of the EYFP signal being directed to the
PDPN+CD31 fraction (Figures 1C and 1D). In situ analysis using(F) 3D reconstruction of T cell zone FRC network, merged channels in left
panel, scale bar = 10 mm.
(G) EYFP expression in perivascular FRCs (arrow); scale bar represents 20 mm.
(H and I) Expression of the homeostatic chemokines CCL21 (H, arrows) and
CCL19 (I, arrows) in EYFP+ FRCs in T cell zones of Ccl19-cre 3 R26-eyfp
inguinal LNs; scale bar represents 20 mm. See also Figure S1.
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Lymphotoxin-b Receptor-Dependent FRC Maturationconfocal laser scanning microscopy revealed that Ccl19-cre+
cells were found mainly in the T cell zone and in interfollicular
regions of the LN (Figure 1E). Three-dimensional (3D) recon-
struction of high-resolution microscopic analyses showed that
the transgene was expressed uniformly in the PDPN+ERTR7+
reticular T cell zone network (Figure 1F). Furthermore, FRCs
ensheathing CD31+ high endothelial venules (HEVs) were trans-
gene-positive (Figure 1G). Ccl19-cre+ LN FRCs expressed
CCL21 (Figure 1H, arrows) and CCL19 (Figure 1I, arrows) indi-
cating that the Ccl19-cre transgene targets both past and pre-
sent CCL19 expression in these nonhematopoietic cells.
Stromal cell composition in spleen is different from LNs
because the double-negative (DN, PDPNCD31) fraction is
dominant and PDPN+CD31+ LECs are not present in this organ
(Onder et al., 2011). Ccl19-cre transgene activity was highest
in the DN cell population (Figures S1C and S1D) with EYFP+ cells
being dispersed in all compartments of the white pulp (Fig-
ure S1E). High densities of transgene-positive cells could be
detected in the area of the marginal zone (Figure S1F) and
around central arterioles (Figure S1G). In contrast, transgene
activity in PP stromal cells was high in PDPN+CD31 cells and
moderate in DN cells with around 80% and 20% of all EYFP+
cells, respectively (Figures S1H and S1I). Because PDPN+
CD31 cells in PPs are still undefined, we have referred to
them as FRC-like cells. Transgene-positive cells were rare in
subdomal areas and more dense in the abluminal part of the
PP (Figure S1J), but associated both with T cell- and B cell-
rich areas (Figure S1K), suggesting that PP FRC-like cells are
involved in the orchestration of both T and B cell responses.
Taken together, the Ccl19-cre transgene permits in vivo target-
ing of LN FRCs and FRC-like cells of PPs.
LN Formation Is Independent of LTbR-Signaling in
Ccl19-Cre+ Mesenchymal Stromal Cells
To assess Ccl19-Cre transgene activity during early LN devel-
opment, we determined reporter gene expression in inguinal
LN anlagen of Ccl19-cre 3 R26-eyfp on E16.5 and E18.5.
We found that Ccl19-cre+ stromal cells were highly abundant
in the E16.5 inguinal LN anlage (Figures 2A; Figure S2A).
Furthermore, the E16.5 inguinal LN anlage had attracted CD4+
LTi cells, which most likely deliver the necessary LTa1b2 for
stimulation of the LTbR on mesenchymal stromal organizer
cells. The number of Ccl19-cre+ stromal cells grew approxi-
mately 3-fold until E18.5, whereas the CD4+ LTi cell population
expanded only modestly (Figure 2B; Figure S2B). To assess
whether Cre-recombinase expression reflected the kinetics of
Ccl19 expression in developing LNs, we determined both Cre-
recombinase and Ccl19 mRNA production in neonatal and
week 2 and six LN homogenates by quantitative RT-PCR
(qRT-PCR). Endogenous Ccl19 expression (Figure 2C) corre-
lated well with Cre expression (Figure 2D) driven by the Ccl19
promoter on the BAC transgene. In contrast, Ltbr expression
fluctuated with the highest expression being measureable in
the neonatal LN (Figure 2E). Confocal microscopic analysis
revealed that Ccl19-cre transgene expression was highly
abundant in neonatal inguinal LNs (Figure 2F, left panels).
3D reconstruction of high-resolution analyses indicated that
Ccl19-cre-expressing stromal cells in the developing LN had
formed a dense network (Figure 2F, right panels) reminiscentof the FRC network in the adult LN. Whereas Ccl19-cre+ stromal
cells expressed low amounts of PDPN, the mesenchymal
markers smooth muscle actin (SMA) and platelet-derived
growth factor receptor-b (PDGFRb) were highly expressed (Fig-
ure 2G), indicating that the Ccl19-cre transgene targets mesen-
chymal stromal cells in developing LNs.
The differentiation of adult stromal cell subpopulations is
thought to depend on LTbR signaling (Randall et al., 2008; van
de Pavert and Mebius, 2010). Because lymphocytes are rare in
neonatal LNs and LTbR-dependent stimulation of mesenchymal
stromal cells is mainly provided by LTi cells (Cupedo et al.,
2004b;White et al., 2007), it is most likely thatCcl19-cre+mesen-
chymal stromal cell in neonatal LNs received LTbR signals from
LTi cells. Interestingly, deletion of the LTbR on Ccl19-cre+
mesenchymal stromal cells did not abrogate LN formation (Fig-
ure 2H). Furthermore, formation of a stromal cell network in
neonatal LNs was not affected by mesenchymal stromal cell-
specific LTbR-ablation (Figure 2H, right panels). Likewise,
expression of SMA and PDGFRb (Figure 2I) was not altered by
the selective LTbR-ablation. Gross pathological examination of
adult Ccl19-cre 3 Ltbrfl/fl mice (4–6 weeks) after injection of
Evan’s Blue revealed that all LNs were present (data not shown).
In contrast,Ccl19-cre-dependent ablation of the LTbR in PPs led
to significantly reduced PP numbers (Figure S2C). Taken
together, these data indicate that Ccl19-cre expression in PP
mesenchymal stromal cells occurs in a developmental window
of critical LTbR-sensitivity. Conversely, Ccl19-cre-expressing
mesenchymal stromal cells in developing LNs do not require
LTbR signals to facilitate LN formation.
LN Structure and Organization in the Absence of FRC-
Specific LTbR Signaling
To assess the impact of Ccl19-cre-mediated LTbR-ablation on
global LN structure and organization, we utilized recently devel-
oped optical projection tomography (OPT) routines (Kumar et al.,
2010). The mesoscopic imaging analysis revealed that LNs of
Ccl19-cre 3 Ltbrfl/fl mice had developed clearly distinguishable
B cell follicles and a HEV network (Figure 3A). Quantification of
the 3D data showed that conditionally LTbR-deficient LNs
were approximately 25%–30% smaller than control LNs (Fig-
ure 3B) and exhibited a comparable reduction in B cell follicle
size (Figure 3C), HEV length (Figure 3D), and complexity of the
HEV network (Figure 3E). The OPT-based finding that LNs with
FRC-specific LTbR-deficiency were still able to establish the
basic LN infrastructure was supported by confocal microscopy,
which showed that LNs had generated clearly distinguishable T
and B cell zones (Figure 3F). The global reduction of LN size
without specific impairment of substructures was reflected by
the comparable reduction of various hematopoietic cell popula-
tions (Figure 3G). Thus, FRC-specific ablation of LTbR-signaling
did not affect the formation of the basic LN structure with clear T
and B cell zone segregation.
To assess whether the conditional LTbR-deficiency affects LN
stromal cell composition, we prepared single-cell suspensions
from Ccl19-cre 3 Ltbrfl/fl and control Ltbr+/+ LNs, depleted
CD45+ hematopoietic cells and stained the enriched stromal
cells with antibodies against PDPN and CD31. Flow cytometric
analysis revealed a loss of PDPN+CD31 cells that coincided
with a significant increase of PDPNCD31 cells (Figure 4A).Immunity 38, 1013–1024, May 23, 2013 ª2013 Elsevier Inc. 1015
Figure 2. Characterization of Ccl19-cre+
Mesenchymal Stromal Cells in Developing
LNs
(A–E) Ccl19-cre 3 R26-eyfp embryos were
analyzed for transgene expressing cells in inguinal
LN anlagen by confocal microscopy at embryonic
days E16.5 (A) and E18.5 (B) by using the indicated
stainings. Left panels show merge of all channels;
scale bars represent 100 mm. Inguinal LNs from
neonatal, 2- and 6-week-old Ccl19-cremice were
analyzed by quantitative RT-PCR for the expres-
sion of Ccl19 (C), Cre recombinase (D), and Ltbr
(E). Values indicate mean ± SEM from two indi-
vidual LNs from three mice analyzed in two inde-
pendent experiments.
(F) Confocal microscopic analysis with single and
combined stainings for the indicated markers of
neonatal inguinal LNs from Ccl19-cre 3 R26-eyfp
mice (confocal plane in left panels). Maximum in-
tensity projection (3D) from z stack (upper right
panel) and magnified 3D rendering of fibroblastic
network (lower right panel, represents boxed area
in upper panel); scale bars represent 100 mm.
(G) Expression of the smooth muscle actin (SMA)
and platelet-derived growth factor receptor-b
(PDGFRb) in neonatal inguinal LNs from Ccl19-cre
3 R26-eyfp mice; scale bar represents 10 mm.
(H) Neonatal inguinal LNs from conditionally LTbR-
deficient Ccl19-cre 3 R26-eyfp mice analyzed by
confocal microscopy (confocal plane in left panels)
with maximum intensity projection (3D) from z
stack (upper right panel) and magnified 3D
rendering of fibroblastic network (lower right
panel, represents boxed area in upper panel);
scale bars represent 100 mm.
(I) Expression of SMA and PDGFRb in conditionally
LTbR-deficient neonatal inguinal LNs; scale bar
represents 10 mm. Representative data from one
out of three independent experiments. See also
Figure S2.
Immunity
Lymphotoxin-b Receptor-Dependent FRC MaturationImportantly, the remaining PDPN+CD31 cells had lost LTbR
expression (Figures 4B and 4C). Confocal microscopic analysis
confirmed the substantial reduction of PDPN expression in
Ccl19-cre 3 Ltbrfl/fl LNs (Figure 4D). However, ERTR7 protein
production and the formation of the fibroblastic reticular network
was not affected by FRC-specific LTbR ablation (Figure 4D).
Moreover, the fibroblastic network still generated ERTR7-en-
sheathed collagen bundles (Figure 4E), i.e., the conduit system,
which rapidly drained small molecules through the T cell zone,
both in the presence and absence of LTbRon T cell zone reticular
cells (Figure 4F). T cell zone reticular cells both in the LN paren-
chyma and surrounding HEVs had lost CCL21 positivity inCcl19-1016 Immunity 38, 1013–1024, May 23, 2013 ª2013 Elsevier Inc.cre 3 Ltbrfl/fl LNs, whereas vascular
endothelial cells in HEVs still produced
this chemokine (Figure 4G). Quantitative
RT-PCR analysis of whole LN homoge-
nates confirmed the substantial loss of
Ccl21 mRNA expression in conditionally
LTbR-deficient LNs (Figure 4H). More-
over, Ccl19-cre 3 Ltbrfl/fl LNs produced
significantly less Ccl19 (Figure 4I) and Il7(Figure 4J) mRNA but almost normal amounts of the B cell
zone chemokine Cxcl13 (Figure 4K). Taken together, these
data show that Ccl19 promoter-dependent LTbR-ablation pro-
foundly altered the LN stromal cell composition and abolished
expression of molecules in T cell zone reticular cells, which are
considered part of the molecular signature of FRCs.
LTbR Promotes FRC Differentiation from
Myofibroblastic Precursors
The pronounced reduction of PDPN+ FRCs and the concomitant
increase in DN stromal cells in LNs Ccl19-cre 3 Ltbrfl/fl sug-
gested that DN LN stromal cells may differentiate into FRCs.
Figure 3. Impact of FRC-Specific LTbR
Signaling on Peripheral LN Structure
(A) Inguinal LNs from 4-week-old Ccl19-cre 3
Ltbrfl/fl and Ltbr+/+ controls were analyzed by OPT
for the presence of the HEV network (MECA-79+)
and B cell follicles (B220+); scale bar represents
500 mm. Quantitative analysis based on OPT data
for (B) LN volume, (C) B cell follicle volume, (D) HEV
network length, and (E) HEV branching points
(mean ± SEM, n = 6 mice pooled from two inde-
pendent experiments).
(F) Confocal microscopic analysis of inguinal LNs
from 4-week-old Ccl19-cre 3 Ltbrfl/fl and Ltbr+/+
controls by using antibodies against T cells (CD4)
and B cells (B220); scale bar represents 200 mm.
(G) Flow cytometry-based quantification of LN
cellularity. Values indicate relative cell numbers in
Ccl19-cre 3 Ltbrfl/fl mice compared to Ltbr+/+
mice (CD4, CD4+ T cells; CD8, CD8+ T cells; BC, B
cells; DC, dendritic cells; MP, macrophages;
mean ± SEM, n = 6 mice from two independent
experiments).
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Lymphotoxin-b Receptor-Dependent FRC MaturationIndeed, in vitro culture of sorted DN cells from Ccl19-cre3 R26-
eyfp LNs in the presence of LTi cells resulted in activation of the
Ccl19 promoter (Figures S3A–S3C). Moreover, upregulation of
EYFP was accompanied by a pronounced increase in PDPN
expression (Figure S3D). Crossing of Ccl19-cre 3 Ltbrfl/fl mice
with R26-eyfp reporter mice confirmed that genetically labeled
(i.e., EYFP+) FRCs emerge from DN precursors in a LTbR gene
dose-dependent fashion (Figures 5A and 5B). LTbR-dependent
FRC maturation was associated not only with the upregulation
of PDPN (Figure 5A) but also with a substantial increase in
ICAM-1 and VCAM-1 expression (Figure 5C). Likewise, EYFP+
PDPNlo cells from Ccl19-cre3 R26-eyfp LNs expressed moder-
ate amounts of ICAM-1 and VCAM-1 (Figure S3E). To further
characterize the phenotypical changes associated with LTbR-
dependent FRC differentiation, we first determined the expres-
sion of myofibroblast and pericyte markers in LN stromal cell
preparations. As shown in Figure 5D, abortion of FRCmaturation
was associated with increased Acta2, Cnn1, and Pdgfrb mRNA
expression, whereas Pdgfra and Cspg4 mRNA expression was
not affected. Confocal microscopy confirmed upregulation of
SMA in myofibroblastic FRC precursors surrounding HEVs (Fig-
ure 5E) and in the T cell zone network (Figure 5F, arrowheads).
Likewise, PDGFRb was upregulated in FRC precursors in both
locations (Figure 5G), whereas perivascularly expressed calpo-
nin-1 was specifically upregulated in myofibroblastic cells in
the T cell zone network (Figure 5H). In contrast, the expression
of the pericyte marker NG2 around small blood vessels was
not affected by the selective LTbR-deficiency (Figure 5I). Thus,
myofibroblastic FRC precursors require LTbR stimulation to ac-
quire the characteristic mature phenotype with the expression of
homeostatic and immune-regulatory molecules.Immunity 38, 1013–10FRC Maturation Guarantees
Immunocompetence during Viral
Infection
To determine the functional conse-
quences of FRC-specific LTbR-defi-
ciency on intranodal T cell migration, weutilized intravital 2-photon microscopy. Adoptive transfer of
C57BL/6 T cells into Ccl19-cre3 Ltbrfl/fl mice or control mice re-
vealed a significant reduction of T cell speed in the T cell zone
parenchyma under conditions of selective LTbR-ablation, with
an average speed close to Ccr7/ T cells (Figure 6A). In
contrast, T cell speed around HEVs was not affected by the
absence of mature FRCs (Figure 6A). Because T cell motility
within the T cell zone parenchyma is partially dependent on
CCR7-mediated signals (Worbs et al., 2007; Figure 6A), we as-
sessed whether LTbR-dependent FRC maturation with upregu-
lation of CCR7 ligands impacts on dendritic cell (DC)-CD8+
T cell interaction. To this end, mouse hepatitis virus (MHV)-spe-
cific CD8+ T cells expressing a T cell receptor recognizing the
H2-Kb-binding S598 epitope were adoptively transferred into
Ccl19-cre 3 Ltbrfl/fl or LTbR-competent control mice. Subse-
quent subcutaneous injection of S598-pulsed DCs revealed
that the conditional LTbR ablation did not lead to a reduction
of DC-mediated T cell activation (Figures S4A and S4B). Next,
we assessed whether the conditional LTbR-deficiency affects
global immune responsiveness in Ccl19-cre 3 Ltbrfl/fl mice by
using systemic infection with the lymphocytic choriomeningitis
virus (LCMV) WE strain, which is controlled in a CD8+ T cell
and perforin-dependent manner (Ka¨gi et al., 1994). Conditionally
LTbR-deficient mice failed to reduce viral titers in LNs and to
clear the virus from peripheral organs such as the kidney by
day 8 postinfection (Figure S4C). Furthermore, Ccl19-cre 3
Ltbrfl/fl mice showed significantly reduced antiviral T cell re-
sponses in LNs (Figure S4D), indicating a globally reduced ca-
pacity to cope with viral infections when LN FRCs fail to generate
an immune-stimulatory environment. However, under conditions
of systemic LCMV distribution, other factors than deficient LN24, May 23, 2013 ª2013 Elsevier Inc. 1017
Figure 4. FRC-Specific LTbR Ablation Alters LN Stromal Cell Composition and Phenotype
(A) Frequency of the major stromal cell populations (PDPNCD31DN cells, PDPN+CD31 [FRC], PDPN+CD31+ [LEC]; PDPNCD31+ [BEC]) in inguinal LNs from
Ccl19-cre 3 Ltbrfl/fl and Ltbr+/+ mice as determined by flow cytometry; values represent mean ± SEM (n = 9 mice from three independent experiments).
(B) Representative LTbR expression patterns on PDPN+CD31 (FRC) stromal cells of Ccl19-cre 3 Ltbrfl/fl (red) and Ltbr+/+ (black) mice determined by flow
cytometry; staining with isotype control antibody in gray.
(C) Summary of LTbR expression displayed as mean fluorescent intensity (MFI), mean ± SEM (n = 4 mice from two independent experiments).
(D–G) Confocal microscopic analysis of inguinal LN stromal cells from 6-week-old Ccl19-cre 3 Ltbrfl/fl and Ltbr+/+ controls. (D) T cell zone reticular network
revealed by ERTR-7 and PDPN staining, merged channels in left panel; scale bar represents 20 mm. (E) High-resolution analysis of T cell zone conduit with
collagen-1 bundles ensheathed by ERTR-7; scale bar represents 2 mm. (F) Drainage of 40 kDa FITC dextran through LN conduits 2 min after subcutaneous
injection. Left panel shows magnified FITC staining in T cell zone; scale bar represents 100/40 mm. (G) Vascular (HEV, high endothelial venule) and T cell zone
stromal cell-associated CCL21 expression, merged channels in left panel, CD31 and CCL21 merge in right panel; scale bar represents 20 mm.
(H–K) Inguinal LNs from 6-week-old Ccl19-cre 3 Ltbrfl/fl and Ltbr+/+ controls were analyzed by quantitative RT-PCR for the expression of Ccl21 (H), Ccl19 (I), Il7
(J), and Cxcl13 (K). Values indicate mean ± SEM from two individual LNs from three mice analyzed in two independent experiments.
Immunity
Lymphotoxin-b Receptor-Dependent FRC MaturationFRCmaturation, such as the lack of PPs, could have contributed
to the observed immunodeficiency in Ccl19-cre 3 Ltbrfl/fl mice.
Therefore, we resorted to an infection system with exclusive
replication in a tissue-draining LN. Following intranasal applica-
tion, the murine coronavirus MHV establishes an infection in the1018 Immunity 38, 1013–1024, May 23, 2013 ª2013 Elsevier Inc.central nervous system (CNS) during which systemic spread is
prevented by swift induction of antiviral immune responses in
the cervical LN (Cervantes-Barraga´n et al., 2009; Gil-Cruz
et al., 2012). Successful control of the acute MHV infection
depends on type I interferon (IFN)-producing plasmacytoid
Immunity
Lymphotoxin-b Receptor-Dependent FRC Maturationdendritic cells (Cervantes-Barragan et al., 2012b) and both CD8+
and CD4+ T cells (Bergmann et al., 2006). To assess the impact
of the relative deficiency of CCR7 ligands in LN stromal cells of
Ccl19-cre3 Ltbrfl/fl mice, we compared conditionally LTbR-defi-
cient mice with plt/plt mice, which lack the expression of CCR7
ligands specifically in secondary lymphoid organs (Gunn et al.,
1999). We found that mice with FRC-specific LTbR deficiency
showed a more dramatic weight loss compared to plt/plt mice
(Figure 6B) and exhibited higher viral titers in the CNS at day
10 postinfection (Figure 6C). The failure of both Ccl19-cre 3
Ltbrfl/fl and plt/pltmice to clear the virus from the CNS and hence
to prevent weight loss is most likely due to the strongly impaired
antiviral T cell response in this vulnerable organ (Figure 6D). Inter-
estingly, recruitment of fully activated IFN-g-secreting effector
T cells (Figures 6E and 6F) was reduced in Ccl19-cre 3 Ltbrfl/fl
compared to plt/pltmice indicating that the impaired antiviral im-
munity inCcl19-cre3 Ltbrfl/fl mice can only be partially explained
by the lack of CCL19 and CCL21 within the CNS-draining LN.
Taken together, these data indicate that LTbR-mediatedmatura-
tion of LN FRCs is critical for the generation of protective antiviral
T cell responses.
DISCUSSION
The assembly of hematopoietic LTi cells and mesenchymal
stromal cells in the LN anlage and their positive feedback-
type interaction is one of the first critical steps in LN formation.
Whereas the molecular details involved in LTi cell-dependent
stimulation of LN development have been thoroughly described
(reviewed in Randall et al., 2008; van de Pavert and Mebius,
2010), the characterization of the stromal side of the LTi-mesen-
chymal LTo cell interaction has suffered from the lack of suitable
tools to dissect ontogeny and function of these cells. We have
addressed this need and describe in this study a model based
on cell-specific expression of the Cre-recombinase that facili-
tates the dissection of mesenchymal stromal cell development
during LN formation and the definition of critical molecular inter-
actions between mesenchymal stromal and hematopoietic
cells.
Mesenchymal precursors in the LN anlage express PDPN, but
are ICAM-1- and VCAM-1-negative (Cupedo et al., 2004a; White
et al., 2007; Be´ne´zech et al., 2010). These precursors develop
into the mesenchymal LTo cell defined by intermediate to high
ICAM-1 and VCAM-1 expression and the concomitant upregula-
tion of essential molecules involved in LN organogenesis,
including CCL19 (Be´ne´zech et al., 2010) Notably, LTbR and the
tumor necrosis factor receptor 1 (TNFR1) are highly expressed
on both the mesenchymal precursor and the mesenchymal
LTo cell (Be´ne´zech et al., 2010) whereby LTbR signaling in the
mesenchymal precursor is critical for the transition to the
ICAM-1+VCAM-1+ mesenchymal LTo cells (White et al., 2007).
However, ablation of LTbR signaling in mesenchymal stromal
cells in the developing LN, i.e., ICAM-1+VCAM-1+ stromal cells
expressing CCL19 in our model, did not prohibit the formation
of LNs and the transition of the mesenchymal stromal cells of
the prenatal LN into myofibroblastic FRC precursors (pre-
FRCs) in postnatal LNs. Importantly, progression toward the im-
mune-stimulatory, mature FRC was strictly dependent on LTbR
signaling. Thus, our data together with previous studies (Whiteet al., 2007; Be´ne´zech et al., 2010) indicate that LN mesen-
chymal stromal cell development is characterized by two distinct
developmental windows of critical LTbR signaling, i.e., initially
during the transition of the mesenchymal precursor to the
mesenchymal LTo cells and as a final maturation stimulus for
T cell zone FRCs.
Development of PPs starts with recruitment of hematopoietic
LTi cells and CD11c-expressing lymphoid tissue initiator cells
(Yoshida et al., 1999; Veiga-Fernandes et al., 2007), which
both serve as sources of LTbR ligands. Again, LTbR-mediated
stimulation of mesenchymal LTo cells triggers production of
homeostatic cytokines and IL-7, which are essential for PP
development (Adachi et al., 1998; Finke et al., 2002). The results
of our study indicate that CCL19 expression in developing PP
mesenchymal stromal cells occurs during a critical phase of
LTbR sensitivity. In contrast, LTbR signaling in Ccl19-Cre+
mesenchymal stromal cells in LN anlagen was not mandatory
for LN development. However, the presence of the LTbR on
endothelial cells appears to be essential during early stages of
LN formation (Onder et al., 2013). Future studies utilizing the
Ccl19-Cre model and other stromal cell-specific Cre-driver
mice will provide a comprehensive characterization of the
critical LTbR-sensitive stage during LTo development in LNs
and PPs.
Several functions have been assigned to FRCs in adult LNs,
such as the generation of the conduit system to facilitate rapid
transfer of small antigens through the T cell zone (Sixt et al.,
2005), regulation of the LN vasculature (Chyou et al., 2008), co-
ordination of T cell and dendritic cell interaction (Baje´noff et al.,
2006), maintenance of T cell homeostasis via IL-7 (Link
et al., 2007), and tolerization of self-reactive T cells (Fletcher
et al., 2010). Our analysis indicates that the basic infrastructure
of the LN including the conduit system and the HEV network is
generated by myofibroblastic FRC-precursors in an LTbR-
independent fashion. It remains to be determined whether
other receptors involved in lymphoid organogenesis such as
RANKL or TNFR1 compensate for the lack of LTbR. Clearly,
LTbR-signaling was necessary for the maturation of FRCs
from PDPN-negative myofibroblastic precursors and the
optimal support of antiviral immunity provided by the
adaptive immune system. Following exposure to inflammatory
stimuli, FRCs respond with an activation program that leads
to upregulation of molecules involved in innate and adaptive
immune responses (Vega et al., 2006; Malhotra et al., 2012).
Hence, it is likely the LTbR-mediated stimulation of pre-FRCs
serves as a critical switch for global immune responsiveness
by unleashing the full immune-stimulatory capacity of the
mature FRC.
In conclusion, our study provides further evidence for a com-
mon theme in mesenchymal stromal cell differentiation, namely
the LTbR-dependent conversion of a sessile myofibroblast into
an immunologically highly active stromal cell. Such profound
LTbR-mediated transformation into FRC-like cells has been
described for vascular smooth-muscle cells during the forma-
tion of organized lymphoid follicles surrounding heavily athero-
sclerotic aortas (Lo¨tzer et al., 2010). Likewise, follicular dendritic
cells (FDCs) that develop in ectopic lymphoid tissues can
descend from PDGFRb-expressing perivascular precursors
(Krautler et al., 2012). Interestingly, only the final maturation ofImmunity 38, 1013–1024, May 23, 2013 ª2013 Elsevier Inc. 1019
Figure 5. LTbR-Dependent FRC Maturation
(A) LN stromal cells from 6-week-old Ccl19-cre 3 R26-eyfpmice with wild-type (+/+, WT) and heterozygously (+/fl) or homozygously floxed (fl/fl) Ltbr loci were as-
sessedby flowcytometry for EYFPexpressionbyusingbackgating.Representativedot plot analysiswith quadstat valuesofCD31andPDPNexpression is shown.
(B) EYFP expression in FRCs and DN cells in the indicated Ltbr genotype of Ccl19-cre 3 R26-eyfp mice; mean ± SEM (n = 3 mice from two independent
experiments).
(C) Representative analysis of ICAM-1 and VCAM-1 expression on Ltbr+/+ DN cells from Ccl19-cre3 R26-eyfpmice (black), EYFP+ Ltbr+/+ FRCs of Ccl19-cre3
R26-eyfp mice (red), and EYFP+ cells of Ccl19-cre 3 R26-eyfpxLtbrfl/fl mice (blue).
(D) Inguinal LNs from 6-week-old Ccl19-cre 3 Ltbrfl/fl and Ltbr+/+ controls were analyzed by quantitative RT-PCR for the expression of Acta2 (SMA), Cnn1
(Calponin-1), Pdgfrb, Pdgfra, and Cspg4 (NG2). Values indicate mean ± SEM from two individual LNs from >3 mice analyzed in two independent experiments.
(legend continued on next page)
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Figure 6. T Cell Function in the Absence of
FRC-Specific LTbR Signaling
(A) Motility of T cells from C57BL/6N (WT) or
CCR7-deficient donors in the T cell zone and
around HEVs in popliteal LNs of Ccl19-cre 3
Ltbrfl/fl (closed symbols) and Ltbr+/+ (open sym-
bols) mice as determined by intravital two-photon
microscopy. Values represent single tracks
pooled from two independent experiments (n = 4
mice, mean indicated by horizontal bar).
(B–D) Ccl19-cre3 Ltbrfl/fl, Ltbr+/+, and plt/pltmice
were infected intranasally with 53 104 pfu of MHV
A59. (B) Weight loss was recorded during
the indicated time period following infection.
Values indicate mean percentage of the initial
weight ± SEM (n = 8 mice per group, one-way
ANOVA with Tukey’s post test). (C) Viral titers in
brain homogenates were determined at day 10
postinfection. Data represent mean viral titers ±
SEM, pooled data from two independent experi-
ments (n = 8 mice); nd, not detectable. (D) T cell
responses were determined by tetramer analysis
of CNS-infiltrating S598-specific CD8+ T cells (left
panel) and intracellular staining for S598-respon-
sive IFN-g-producing CD8+ T cells (middle panel),
and M133-responsive IFN-g-producing CD4+
T cells (right panel) on day 10 post infection.
Values indicate mean percentages ± SEM of
specific cells in the respective CD8+ or CD4+
T cell population (n = 8 mice per group). See also
Figure S4.
(D–F) T cell responses were determined by
tetramer analysis of CNS-infiltrating S598-specific
CD8+ T cells (D) and intracellular staining for
S598-responsive IFN-g-producing CD8+ T cells
(E), and M133-responsive IFN-g-producing CD4+
T cells (F) on day 10 postinfection. Values indicate
mean percentages ±SEM of specific cells in the
respective CD8+ or CD4+ T cell population (n = 8
mice per group).
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Lymphotoxin-b Receptor-Dependent FRC MaturationFDCs into immunologically active cells was dependent on lym-
photoxin-mediated signals. Whereas FDCs in ectopic lymphoid
tissues can emerge from ubiquitous perivascular precursors
(Krautler et al., 2012), mature LN FRCs originate from PDPN-
negative myofibroblastic progenitors that can form the global
stromal cell network of the developing LN and that are distrib-
uted throughout the T cell zone and interfollicular regions of
the adult LN. Despite the remaining unknowns concerning the
differentiation of mesenchymal stromal cells of secondary and
tertiary lymphoid organs, the results of this study suggest that(E–I) Confocal microscopic analysis of inguinal LN stromal cells from 6-week-old Ccl19-cre3 R26-eyfpxLtbrfl
Reconstruction of perivascular (E) and T cell zonal (F) stromal cell network by analyzing CD31, SMA, and
perivascular EYFP expression, arrows indicate SMA+EYFP+ cells in orthogonal sections, and scale bars rep
(G) Analysis of perivascular and T cell zonal expression of EYFP and PDGFRb; scale bar represents 20 mm, al
perivascular and network-forming cells expressing CNN1 (H) and NG2 (I) and EYFP, merged channels in left
data out of three independent experiments. See also Figure S3.
Immunity 38, 1013–10timing of LTbR targeting for the attenua-
tion of exaggerated immune responses
may be critical (Browning, 2008), i.e.,
mesenchymal stromal cell differentiationshould be blocked before the stage of the immunologically fully
active FRC—or FDC—has been reached.
EXPERIMENTAL PROCEDURES
Mice
BAC-transgenic C57BL/6N-Tg(Ccl19-Cre)489Biat (Ccl19-Cre) mice were gener-
ated as described previously (Onder et al., 2011). The coding sequence for the
Cre-recombinase and a truncated form of the human CD4 gene, separated by
an IRES sequence and including a stop codon, was inserted into Ccl19 exon 1
utilizing the endogenous ATG translation start codon on the 180 kb BAC RP23/fl mice and Ltbr+/+ Ccl19-cre3 R26-eyfp controls.
EYFP expression is shown. Arrowheads indicate
resent 10 mm.
l panels show merged channels. Reconstruction of
panels; scale bars represent 30 mm; representative
24, May 23, 2013 ª2013 Elsevier Inc. 1021
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Lymphotoxin-b Receptor-Dependent FRC Maturation446D10 (Invitrogen). Because the Ccl21b gene is in close proximity to Ccl19,
the Ccl21b gene was deleted on the BAC by inserting the human CD8 gene
into the first exon of the Ccl21b locus. The BAC carried at least 90 kb of
sequence upstream of the Ccl19 transcription start site. Integration of the
Cre-recombinase was confirmed by Southern blot analysis. Modified BACs
were screened with 50ATG PCR (forward 50-GCACACGAATGTGGATGTTC-
30, reverse 50-CTGCACACAGACAGGAGCAT-30) and 30polyA PCR (forward
50-ATGTGGCAGTGTCTGCTGAG-30, reverse 50-CCTGTAGCCAGAGGTTG
GAG-30). Founder lines were genotyped by PCR by using the following
primers: forward 50-TCTCTGCCCAGAGTCATCCT-30, reverse 50-ATGC
TCCTGTCTGTGTGCAG-30. B6.129X1-Gt(ROSA)26Sortm1Hjf (R26-eyfp) mice
were purchased from The Jackson Laboratories. Ltbrfl/fl mice (Wimmer et al.,
2012) were described previously. C57BL/6N mice were obtained from Charles
River (Sulzfeld, Germany) and plt/plt mice were obtained from the Institute of
Laboratory Animal Sciences (University of Zurich, Switzerland). All animals
were kept under conventional conditions in individually ventilated cages.
Experiments were performed in accordance with Swiss federal and cantonal
guidelines (Tierschutzgesetz) under the permission numbers SG11/05 and
SG11/04 granted by the Veterinary Office of the Canton of St. Gallen.
Preparation of Stromal Cells
LNs were dissected into small pieces and transferred into a 24-well dish filled
with RPMI 1640 medium containing 2% FCS, 20 mM HEPES (all from Lonza),
1 mg/ml Collagenase Type IV (Sigma), and 25 mg/ml DNaseI (Applichem).
Dissociated LNs were incubated at 37C for 30min. After enzymatic digestion,
cell suspensions were washed with PBS containing 0.5% FCS and 10 mM
EDTA. To enrich the stromal cell fraction, hematopoietic cells were depleted
by incubating the cell suspension with MACS anti-CD45 Microbeads and
passing over a MACS LS column (Miltenyi).
Flow Cytometry and Cell Sorting
Single-cell suspensionswere incubated for 20min at 4C inPBS containing 1%
FCS and 10 mM EDTA with the following fluorescently labeled antibodies:
anti-CD45, anti-PDPN, anti-CD31, anti-LTbR, anti-VCAM-1, and anti-ICAM-1
(all from eBioscience), anti-CD3, anti-CD4, anti-CD8, anti-B220, anti-CD11c,
anti-CD11b, anti-F4/80 (all from BD Biosciences). Cells were acquired with
a FACS Canto (BD Biosciences) and analyzed by using FlowJo software
(Treestar). Cell sorting was performed by using a FACS Aria cell sorter (BD
Biosciences).
Quantitative Real-Time PCR
Total cellular RNA was extracted from homogenized tissues and sorted cells
by using TRIZOL reagent (Invitrogen) following the manufacturers’ protocol.
cDNA was prepared by using cDNA archive kit (Applied Biosystems) and
quantitative RT-PCR was performed by using the Light Cycler-FastStart
DNA Master SYBR Green I kit (Roche Diagnostics) on a LightCycler machine
(Roche Diagnostics). mRNA expression was measured by using the following
primers: Ccl19 forward CTGCCTCAGATTATCTGCCAT, reverse AGGTAGCG
GAAGGCTTTCAC; Ccl21 forward AAGGCAGTGATGGAGGGG, reverse
CGGGGTAAGAACAGGATTG; tata-box binding protein (tbp) forward
CCTTCACCAATGACTCCTATGAC, reverse CAAGTTTACAGCCAAGATTCAC;
Cxcl13 forward ACAGCAACGCTGCTTCTCC, reverse AATCACTCCAGAA
CACCTAC; cre forward ATGCTCCTGTCTGTGTGCAG, reverse GGAGGGCA
GATCTCCTGTG; Acta2 (QuantiTect Primer Assay QT00140119, QIAGEN);
cspg4 (QuantiTect Primer Assay QT00143220); Cnn1 (QuantiTect Primer
Assay QT00105420); Pdgfra (QuantiTect Primer Assay QT00140021); Pdgfrb
(QuantiTect Primer Assay QT00113148).
Immunohistochemistry
Lymph nodes were fixed overnight in freshly prepared 4% paraformaldehyde
(Merck) at 4C under agitation. Fixed LNs were embedded in 4% low melting
agarose (Invitrogen) in PBS and sectioned with a vibratome (Leica VT-1200).
We blocked 20–30 mm thick sections in PBS containing 10% FCS, 1 mg/ml
anti-Fcg receptor (BD Biosciences), and 0.1% Triton X-100 (Sigma). Sections
were incubated overnight at 4C with the following antibodies: anti-PDPN,
anti-B220, anti-CD31, anti-CD4, anti-PDGFRb, anti-LyveI, anti-E-Cadherin
(all from eBioscience), anti-NG2 (Millipore), anti-SMA (Sigma), anti-EYFP
(Clontech), anti-Calponin1, anti-CCL21, anti-CCL19, anti-Collagen I, anti-1022 Immunity 38, 1013–1024, May 23, 2013 ª2013 Elsevier Inc.ERTR-7 (all from Abcam). Unconjugated antibodies were detected with the
following secondary antibodies: Dylight649-conjugated anti-rat-IgG,
Alexa488-conjugated anti-rabbit-IgG, Dylight549-conjugated anti-syrian ham-
ster-IgG, and Dylight549-conjugated Streptavidin (all purchased from Jackson
Immunotools). Microscopical analysis was performed by using a confocal
microscope (Zeiss LSM-710) and images were processed with ZEN 2010 soft-
ware (Carl Zeiss, Inc.) and Imaris (Bitplane).
Injection of Soluble Tracers
Mice were injected with 50 mg of 40 kDa FITC-Dextran (Molecular Probes) into
the footpad and sacrificed two minutes after injection. Popliteal and inguinal
LNs were excised and prepared for immunohistochemistry.
Optical Projection Tomography (OPT)
Mice received an intravenous injection of fluorescently labeled MECA-79
(15 mg) to label the HEV network. After 15 min, mice were sacrificed, LNs
were carefully excised, and surrounding tissue was removed under a stereo-
microscope. Sample preparation and OPT was performed as previously
described (Kumar et al., 2010).
Two-Photon Intravital Microscopy
Purified T cells were fluorescently labeled with 2.5 mM chloromethyl-benzoyl
amino-tetramethylrhodamine (CMTMR) or CFSE for 15 min at 37C. After
washing, labeled T cells were injected intravenously into sex-matched mice,
which were 24 hr later anesthetized and surgically prepared to expose the right
popliteal lymph node. Two-photon microscopy (2PM) was performed as
described (Soriano et al., 2011).
Virus Infections
Mice were infected intranasally with 5 3 104 pfu of MHV A59 as previously
described (Cervantes-Barraga´n et al., 2009). MHV titers were determined by
standard plaque assay by using L929 cells. Analysis of MHV-specific CD8
T cell responses was performed by using PE-conjugated MHV S598/H-2Kb
tetramers (Sanquin, Amsterdam, The Netherlands) as described (Cervantes-
Barraga´n et al., 2012a). For peptide-specific cytokine production, 106 lympho-
cyte-enriched CNS cells were restimulated with S598 or M133 peptides and
IFN-g secretion was determined by flow cytometry as described (Cervantes-
Barraga´n et al., 2012a). LCMV infection and assessment of viral titers and anti-
viral T cell responses were done as described previously (Cervantes-Barraga´n
et al., 2012b).
Statistical Analysis
2PM and OPT data were analyzed with Volocity (Perkin Elmer). All statistical
analyses were performed with Prism 5.0 (Graphpad Software Inc.). Data
were analyzed with the nonpaired Student’s t test or as indicated in the figure
legend. A p value of < 0.05 was considered as significant.
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